Trimethyl Orthoformate is a reagent in the synthesis of CDK2/Cyclin A as antitumor agents derived from 3-aminopyrazole molecules. Also used in the preparation of PLD1/PLD2 selective inhibitors that decrease invasive migration of glioblastoma cells often associated with tumor progression.